相关实验视频

Updated: Jan 9, 2026

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

介质素-2表面显示的M1巨细胞衍生的细胞外囊,用于调节瘤微环境

Kyeong Tae Kim¹, Jeong Hyun Lee¹, Su Jin Kang¹

¹Department of Bioengineering and Nano-Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea.

International journal of nanomedicine

|December 3, 2025

概括

工程外细胞囊泡 (M1EV_IL2) 通过激活巨细胞和T细胞来重新编程瘤微环境. 这种新型的癌症免疫疗法增强了先天性和适应性免疫反应,以提高治疗疗效.

科学领域:

免疫学免疫学免疫学
生物技术是生物技术.
癌症研究癌症研究

背景情况:

癌症免疫疗法面临着由于免疫抑制性瘤微环境 (TME) 的挑战,其特点是M2巨细胞和非效应性T细胞.
调节TME对于开发有效的癌症免疫疗法至关重要.

研究的目的:

开发一种多功能癌症免疫治疗剂,M1EV_IL2,通过表面修改M1巨细胞衍生的细胞外囊泡 (M1EV) 来显示介质素-2 (IL-2).
设计M1EV_IL2以同时调节TME内的先天性 (巨细胞) 和适应性 (T细胞) 免疫反应.

主要方法:

使用代谢糖基工程来引入亚齐德群的工程M1EV,然后通过生物对等化学来显示IL-2,创建M1EV_IL2.
使用尺寸排除染色学 (SEC) 和纳米粒子追踪分析 (NTA) 净化和特征M1EV_IL2.
在体外评估M1EV_IL2对巨细胞再极化和T细胞激活,以及体外评估T细胞增殖,细胞因子分泌和激活标记表达.

主要成果:

M1EV_IL2表现出稳定的IL-2显示,并保留了EV特性,通过上调M1标记物 (IL-1β,CXCL10) 和下调M2标记物 (CD206) 来诱导M2-M1巨细胞再极化.
M1EV_IL2激活了CD4+T细胞,并将原始CD8+T细胞转化为T细胞.
观察到增强的T细胞增殖和抗瘤细胞因子的分泌.

结论:

M1EV_IL2通过共同激活巨细胞和T细胞,有效地重塑瘤免疫场景,增强先天性和适应性免疫力.
这种方法为直接向瘤治疗提供了潜在的替代方案,旨在减轻副作用并改善癌症治疗的整体治疗结果.

关键词:

在T细胞激活过程中,癌症免疫疗法免疫疗法细胞外囊泡中的细胞外囊泡.介质蛋白-2 介质蛋白-2 介质蛋白-2 巨细胞再极化发生.

更多相关视频

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

In Vitro Assay to Study Tumor-macrophage Interaction

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.